RT Book, Section A1 Fayne, Rachel A1 Nichols, Anna A2 Nouri, Keyvan SR Print(0) ID 1194728821 T1 Skin Cancer Vaccines T2 Skin Cancer: A Comprehensive Guide YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781260453003 LK dermatology.mhmedical.com/content.aspx?aid=1194728821 RD 2024/03/28 AB SUMMARYVaccines are traditionally used for the prevention of infections and related sequelae, but they have been repurposed as a novel treatment platform for several types of cancer.Currently, there is only one skin cancer vaccine (T-VEC; oncolytic herpesvirus vaccine) approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced melanoma. Several other oncolytic virus vaccines and other vaccine platforms are in phases 1, 2, and 3 testing for the treatment of advanced melanoma.The FDA-approved quadrivalent and 9-valent human papillomavirus (HPV) vaccines have been used in a few reports to prevent and treat nonmelanoma skin cancer and show promising initial results.